SNCA and Parkinson disease: Parkinson’s disease (PD) is a progressive neurodegenerative disorder, potentially with several triggers and etiologies for the pathogenic processes that converge on the accumulation of misfolded α-synuclein (α-syn) in Lewy bodies and neurites [1] and the degeneration of dopamine (DA) neurons in the substantia nigra.